Ventyx Biosciences, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ACLX
Arcellx, Inc. |
$75.01 | $2.72 B | -49.3 | 163 | $107.94 M |
![]() ASND
Ascendis Pharma A/S |
$140.28 | $7.77 B | -14.19 | 1017 | $363.64 M |
![]() CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
![]() DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
![]() GPCR
Structure Therapeutics Inc. |
$27.50 | $2.47 B | -23.59 | 163 | $0 |
![]() IDYA
IDEAYA Biosciences, Inc. |
$25.69 | $2.88 B | -19 | 131 | $7.00 M |
![]() IMCR
Immunocore Holdings plc |
$29.87 | $2.08 B | -26.72 | 493 | $310.20 M |
![]() NUVL
Nuvalent, Inc. |
$78.09 | $5.11 B | -32.72 | 142 | $0 |
![]() PCVX
Vaxcyte, Inc. |
$85.99 | $7.72 B | -16.54 | 414 | $0 |
![]() PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
![]() REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
![]() SNDX
Syndax Pharmaceuticals, Inc. |
$13.69 | $1.66 B | -6.02 | 270 | $23.68 M |
![]() TVTX
Travere Therapeutics, Inc. |
$18.71 | $542.80 M | -1.32 | 385 | $233.18 M |
![]() UTHR
United Therapeutics Corporation |
$355.39 | $12.20 B | 13.02 | 1305 | $2.88 B |
![]() VRNA
Verona Pharma plc |
$44.81 | $983.52 M | -15.16 | 209 | $42.28 M |